NanoMedTrix LLC (AKA: NMTx) Profile last edited on: 7/24/19
CAGE: 6T4P8
UEI: Q4SGGWL49CE4
Business Identifier: Nanomaterials for regenerative medicine applications 
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
Location: Single
Congr. District: 02
County: Johnson
Congr. District: 02
County: Johnson
Public Profile
Spun out of research at the University of Iowa, NanoMedTrix LLC develops nanoparticles for regenerative medicine applications. In cancer, NanoMedtrix material has been designed to target solid tumors such as: bladder, colorectal and neural tumors. The same nano-compounds are adjustable to provide valuable information on the disease process of multitude illnesses. The company's products combine fluorescence, magnetic resonance imaging (MRI) or computer tomography (CT) with Ultrasound Imaging (UI) signaling capability. Its customizable compounds can be engineered to tag tumors or cells of interest.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
1-4Revenue Range
Less than .5MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
N/AAwards Distribution by Agency
Most Recent SBIR Projects
| Year | Phase | Agency | Total Amount | |
|---|---|---|---|---|
| 2022 | 2 | NIH | $2,350,240 | |
| Project Title: Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles | ||||
| 2014 | 1 | NSF | $179,999 | |
| Project Title: Commercialization of Multi-Modal Nanoparticle Imaging Contrast Agents for Multi-Scale Use in Biomedical Applications | ||||
Key People / Management
Joe Assouline -- President
Sean Sweeney -- Director of Manufacturing and Engineering
Sean Sweeney -- Director of Manufacturing and Engineering
Company News
There are no news available.
